Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 3,323 shares of the business’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $42.12, for a total value of $139,964.76. Following the completion of the sale, the director now owns 14,830 shares in […]

Skye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report) CFO Kaitlyn Arsenault sold 43,206 shares of Skye Bioscience stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $4.99, for a total transaction of $215,597.94. Following the transaction, the chief financial officer now owns 166,342 shares in […]

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) insider Teresa Mccarthy sold 25,000 shares of Avidity Biosciences stock in a transaction on Monday, November 18th. The shares were sold at an average price of $41.14, for a total transaction of $1,028,500.00. Following the transaction, the insider now owns 94,018 shares in the company, valued at […]

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 3,323 shares of the firm’s stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of $42.12, for a total transaction of $139,964.76. Following the completion of the sale, the director now owns 14,830 shares of […]

Skye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report) Director Paul A. Grayson sold 86,244 shares of Skye Bioscience stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $4.99, for a total transaction of $430,357.56. Following the completion of the sale, the director now owns 259,701 […]